| Primary |
| Pharyngolaryngeal Pain |
11.5% |
| Tonsillitis |
11.5% |
| Bronchitis |
7.7% |
| Ear Infection |
7.7% |
| Urinary Tract Infection |
7.7% |
| Antibiotic Therapy |
3.8% |
| C-reactive Protein Increased |
3.8% |
| Cyst |
3.8% |
| Depression |
3.8% |
| Infection |
3.8% |
| Infection Prophylaxis |
3.8% |
| Influenza |
3.8% |
| Lymphadenopathy |
3.8% |
| Nasopharyngitis |
3.8% |
| Orthopedic Procedure |
3.8% |
| Productive Cough |
3.8% |
| Streptococcal Infection |
3.8% |
| Temperature Intolerance |
3.8% |
| Upper Respiratory Tract Inflammation |
3.8% |
|
| Vomiting |
12.0% |
| Diarrhoea Haemorrhagic |
8.0% |
| Dyspnoea |
8.0% |
| Toxic Epidermal Necrolysis |
8.0% |
| Anaphylactic Shock |
4.0% |
| Drug Abuse |
4.0% |
| Malaise |
4.0% |
| Nausea |
4.0% |
| Olfactory Nerve Disorder |
4.0% |
| Palpitations |
4.0% |
| Pneumonia |
4.0% |
| Pruritus |
4.0% |
| Rash Macular |
4.0% |
| Rash Maculo-papular |
4.0% |
| Sepsis |
4.0% |
| Skin Exfoliation |
4.0% |
| Skin Test Positive |
4.0% |
| Stevens-johnson Syndrome |
4.0% |
| Stomatitis |
4.0% |
| Streptococcal Infection |
4.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
25.0% |
| Anxiety |
10.0% |
| Hypoxia |
10.0% |
| Prophylaxis |
10.0% |
| Prostate Cancer |
10.0% |
| Bronchitis |
5.0% |
| Cardiac Asthma |
5.0% |
| Cough |
5.0% |
| Hypertension |
5.0% |
| Tendonitis |
5.0% |
| Tracheobronchitis |
5.0% |
| Urinary Tract Infection |
5.0% |
|
| Drug Hypersensitivity |
38.9% |
| Tumour Lysis Syndrome |
11.1% |
| Anaphylactic Shock |
5.6% |
| Injection Site Swelling |
5.6% |
| Nausea |
5.6% |
| Peripheral Ischaemia |
5.6% |
| Rash |
5.6% |
| Respiratory Failure |
5.6% |
| Ventricular Extrasystoles |
5.6% |
| Vomiting |
5.6% |
| Weight Increased |
5.6% |
|
| Concomitant |
| Drug Use For Unknown Indication |
15.7% |
| Product Used For Unknown Indication |
14.8% |
| Hypertension |
13.6% |
| Depression |
9.4% |
| Diabetes Mellitus |
5.4% |
| Pain |
5.1% |
| Arthralgia |
4.8% |
| Anxiety |
3.3% |
| Conjunctivitis |
3.0% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
3.0% |
| Prophylaxis |
3.0% |
| Upper Respiratory Tract Infection |
3.0% |
| Atrial Fibrillation |
2.4% |
| Acne |
2.1% |
| Bone Density Decreased |
2.1% |
| Chronic Obstructive Pulmonary Disease |
2.1% |
| High Density Lipoprotein Decreased |
1.8% |
| Osteopenia |
1.8% |
| Rheumatoid Arthritis |
1.8% |
| Dyspnoea |
1.5% |
|
| Vomiting |
12.5% |
| Sinusitis |
7.8% |
| Thrombocytopenia |
7.8% |
| Tooth Extraction |
7.8% |
| Cellulitis |
6.3% |
| Ventricular Septal Defect |
6.3% |
| Weight Decreased |
6.3% |
| Deep Vein Thrombosis |
4.7% |
| Toothache |
4.7% |
| Vision Blurred |
4.7% |
| Weight Gain Poor |
4.7% |
| Injection Site Infection |
3.1% |
| Proctitis Ulcerative |
3.1% |
| Tremor |
3.1% |
| Unresponsive To Stimuli |
3.1% |
| Urinary Tract Infection |
3.1% |
| Ventricular Tachycardia |
3.1% |
| Wheezing |
3.1% |
| Xerosis |
3.1% |
| Acute Hepatic Failure |
1.6% |
|
